About Allogeneic Cell Therapies Summit 2021

Patient-specific cell therapies have changed the face of cancer treatment, but with price points sky high and laborious manufacturing processes, this cure is out of reach for many patients.

The 3rd annual Allogeneic Cell Therapies Summit is the only industry-focused meeting dedicated to accelerating the clinical translation of allogeneic cell therapy, to provide an affordable and accessible treatment for patients globally.

With 3 tracks of unrivalled content spanning translation, manufacturing and commercialization, join with your team to achieve next generation gene engineering to overcome rejection, improve persistence through arming and dosing, and optimize CMC and quality control to achieve long term stability at high yields and high efficacy.

200 senior level drug developers will be collaborating online this May to achieve the holy grail of allogeneic therapies. Don’t miss your chance to improve your competitive intelligence and capitalize on the simplified logistics, time to delivery and reduced cost of off-the-shelf approaches.